Who owns 53220K954 - LIGAND PHARMACEUTICALS INC - COM NEW - Put based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

LIGAND PHARMACEUTICALS INC - COM NEW - Put Institutional Ownership

CUSIP 53220K954 is the security identifier used in SEC filing datasets for 53220K954 - LIGAND PHARMACEUTICALS INC - COM NEW - Put.

CUSIP: 53220K954

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

What is CUSIP 53220K954?
CUSIP 53220K954 identifies 53220K954 - LIGAND PHARMACEUTICALS INC - COM NEW - Put in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Open recent reporting periods for CUSIP 53220K954:

As of 31 Dec 2025, 0 institutional investors reported holding shares of LIGAND PHARMACEUTICALS INC - COM NEW - Put.

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Price (Median)	Investors
2025 Q4				$567,210	$189.07	0
2025 Q3				$0	$189.07	0
2025 Q2				$11,368	$113.68	0
2025 Q1				$0	$189.07	0
2024 Q4				$10,000	$100.00	0
2024 Q3				$0	$189.07	0
2024 Q2				$8,000	$80.00	0
2024 Q1				$467,500	$72.98	0
2023 Q4				$456,100	$71.07	0
2023 Q3				$1,024,632	$59.92	0
2023 Q2				$280,250	$71.76	0
2022 Q4				$0	$189.07	0
2022 Q3				$43,000	$86.00	0
2022 Q2				$80,000	$88.89	0
2022 Q1				$123,000	$111.82	0
2021 Q4				$648,000	$154.28	0
2021 Q3				$510,000	$137.28	0
2021 Q2				$380,000	$131.01	0
2021 Q1				$19,421,000	$7689.86	0
2020 Q4				$6,355,000	$5020.74	0
2020 Q3				$5,852,000	$4806.28	0
2020 Q2				$11,878,000	$5646.84	0
2020 Q1				$4,574,000	$72.73	0
2019 Q4				$43,050,000	$104.29	0
2019 Q3	0	$0	-$17,000	$40,821,000	$99.55	0
2019 Q2	100	$17,000		$1,791,000	$170.00	1
2019 Q1	100	$17,000	+$17,000	$15,088,000	$125.71	1
2018 Q4				$37,480,000	$135.70	0
2018 Q3				$1,729,000	$13845.64	0
2018 Q2				$1,409,000	$10463.21	0
2018 Q1				$5,000	$263.16	0
2017 Q4				$27,000	$135.00	0
2017 Q3				$27,000	$135.00	0
2017 Q2				$2,125,000	$121.43	0
2017 Q1				$12,892,000	$169.14	0
2016 Q4				$8,001,000	$101.61	0
2016 Q3				$95,000	$550.00	0
2016 Q2				$1,894,000	$119.31	0
2016 Q1				$2,133,000	$107.14	0
2015 Q4				$1,485,000	$108.38	0
2015 Q3				$967,000	$85.62	0
2015 Q2				$3,047,000	$100.89	0
2015 Q1				$1,986,000	$77.14	0
2014 Q4				$416,000	$53.21	0
2014 Q3				$1,170,000	$47.01	0
2014 Q2				$3,469,000	$62.28	0
2014 Q1				$2,361,000	$67.28	0